R.PR
REGISTERED-PRINCIPAL REGISTER
12/07/2021
Back to search
Official data from USPTO
ETERA SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ETERA SOLUTIONS
ST13
US500000090151885Class
35, 42
Filing
90151885
Registration
6579174
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/07/2021
Classification
Registered
Trademark type
Word
Nice classes
35, 42
Filing date
09/01/2020
Registration date
12/07/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/07/2021
Last transaction
12/07/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2008-02-00
First use in commerce
2008-10-00
Drawing code
4
Owner type
16
Owner location
Canton, MA
Examiner
DAWE III, BILL
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ETERA SOLUTIONS, LLC
Representatives
Aaron Y. Silverstein SAUNDERS & SILVERSTEIN LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business organization and management consulting in the fields of life scienceshealth carebiotechnologypharmaceuticalsclinical developmentclinical trials; Business consulting services in the field of budgeting management strategy for the life sciencehealth carebiotechnologypharmaceuticalclinical developmentclinical trial industries; Business consulting services in the fields of in-sourcing strategyproviding reviewadviceguidance concerning client's in-house technical resourcesidentifying and recommending the required skillsnumber of employeestiming of workoutsourcing strategyproviding reviewadviceguidance concerning client's external technical resourcesidentifying and recommending the required skillsnumber of employeestiming of workfor the life sciencehealth carebiotechnologypharmaceuticalclinical developmentclinical trial industries; Business consulting services in the field of business process improvement strategyproviding reviewadviceguidance concerning client's internal technical business processes to determine areas of improvement for quality and efficiency for the life sciencehealth carebiotechnologypharmaceuticalclinical developmentclinical trial industries; Business consulting services in the fields of technology business strategy for the life sciencehealth carebiotechnologypharmaceuticalclinical developmentclinical trial industries; Business consulting services in the field of developing standard operating business procedures for the life sciencehealth carebiotechnologypharmaceuticalclinical developmentclinical trial industries; Business servicesnamely staff managementproviding temporary management and directionoversightinstructionguidance of the performance to achieve pre-determined objectives and goals for clients' employeestemporary employeessubcontractorsvendorsbusiness teamsorganizational business departments for the life sciencehealth carebiotechnologypharmaceuticalclinical developmentclinical trial industries
Class 42
Computer software development in the fields of life scienceshealth carebiotechnologypharmaceuticalsclinical developmentclinical trials; Computer software consultancy in the fields of life scienceshealth carebiotechnologypharmaceuticalsclinical developmentclinical trials; Testing of computer software in the fields of life scienceshealth carebiotechnologypharmaceuticalsclinical developmentclinical trials; Maintenance of computer software in the fields of life scienceshealth carebiotechnologypharmaceuticalsclinical developmentclinical trials
Publications
History of USPTO decisions and trademark events.
29 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/21/2021
PUBO
PUBLISHED FOR OPPOSITION
09/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/17/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/22/2021
GNRT
NON-FINAL ACTION E-MAILED
07/22/2021
CNRT
NON-FINAL ACTION WRITTEN
07/22/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/22/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/17/2021
GNRT
NON-FINAL ACTION E-MAILED
03/17/2021
CNRT
NON-FINAL ACTION WRITTEN
03/17/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/16/2021
GNRT
NON-FINAL ACTION E-MAILED
03/16/2021
CNRT
NON-FINAL ACTION WRITTEN
03/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/18/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2021
GNRT
NON-FINAL ACTION E-MAILED
01/07/2021
CNRT
NON-FINAL ACTION WRITTEN
01/07/2021
DOCK
ASSIGNED TO EXAMINER
01/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2020
NWAP
NEW APPLICATION ENTERED
09/04/2020
Continuous trademark protection
Get notified about every new filing that threatens ETERA SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.